Sigurdur Kristinsson (@sykristinsson) 's Twitter Profile
Sigurdur Kristinsson

@sykristinsson

Professor of hematology at Univ of Iceland. Treatment and research on plasmacell diseases. PI for @iStopMM
pubmed.ncbi.nlm.nih.gov/?term=kristins…

ID: 3078258341

calendar_today07-03-2015 22:33:23

973 Tweet

1,1K Followers

233 Following

Sigurdur Kristinsson (@sykristinsson) 's Twitter Profile Photo

Calling all myeloma experts, nurses, and patients!🩺🧬 The iStopMM team & International Myeloma Foundation need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

There’s no right answer, so tell us yours! Great to see iStopMM group at it again - patients, nurses, APPs, and physicians can fill out easy survey (written in patient-friendly language) about what % #MMsm risk and pt scenarios might prompt BMBx. redcap.link/biopsysurvey

Sigurdur Kristinsson (@sykristinsson) 's Twitter Profile Photo

Thank you all for participating in our survey! It is still open for those that have not completed it yet. Your input is of great importance! Take part & help spread the word: redcap.link/biopsysurvey

Omar Nadeem (@omarnadeemmd) 's Twitter Profile Photo

For those at #AACR25 come join our session of “Myeloma as a Model for Early Interception” covering topics of biology of precursor MM Gaddy Getz , screening for MGUS Sigurdur Kristinsson and role of early intervention co-chaired with Gaddy Getz #AACR2025 #mmsm

For those at #AACR25 come join our session of “Myeloma as a Model for Early Interception” covering topics of biology of precursor MM <a href="/gaddyg/">Gaddy Getz</a> , screening for MGUS <a href="/sykristinsson/">Sigurdur Kristinsson</a> and role of early intervention co-chaired with <a href="/gaddyg/">Gaddy Getz</a>  #AACR2025 #mmsm
Blood Cancer Journal (@bloodcancerjnl) 's Twitter Profile Photo

Revised free light chain (FLC) reference intervals enhance risk stratification in monoclonal gammopathy of undetermined significance. MGUS #OpenAccess ⁦Sigurdur Kristinsson⁩ nature.com/articles/s4140…

Simon Stern (@drsstern) 's Twitter Profile Photo

Helpful paper validating the revised free light chain reference ranges generated by the iStopMM study. I've already found them useful in providing reassurance to GPs enquiring about patients with "abnormal" SFLC ratios that are, in fact, normal. Sigurdur Kristinsson #mmsm

Samer Al Hadidi, MD,MS,FACP (@hadidisamer) 's Twitter Profile Photo

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance iStopMM JAMA Oncology #mmsm jamanetwork.com/journals/jamao… Important data coming to support need for new ranges of normal free light chains based on eGFR👇

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance <a href="/iStopMM/">iStopMM</a> 

<a href="/JAMAOnc/">JAMA Oncology</a> #mmsm 

jamanetwork.com/journals/jamao…

Important data coming to support need for new ranges of normal free light chains based on eGFR👇
Kenar Jhaveri (@kdjhaveri) 's Twitter Profile Photo

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance | Nephrology | JAMA Oncology | JAMA Network jamanetwork.com/journals/jamao…

Þórir Long (@thorirlong) 's Twitter Profile Photo

🧵1/ Our paper is out! A new study from the iStopMM team in JAMA Oncology shows how revising free light chain (FLC) reference intervals can reduce false positives for light chain MGUS (LC-MGUS). Let’s break it down 👇 jamanetwork.com/journals/jamao…